Empower Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322M Buy
268,075
+8,303
+3% +$8.48M 0.77% 27
2026
Q1
$239M Buy
259,772
+10,171
+4% +$10.3M 0.62% 32
2025
Q4
$268M Buy
249,601
+4,005
+2% +$3.83M 0.72% 31
2025
Q3
$187M Buy
245,596
+19,662
+9% +$14.6M 0.52% 34
2025
Q2
$176M Buy
225,934
+13,415
+6% +$10.4M 0.53% 36
2025
Q1
$176M Buy
212,519
+19,033
+10% +$15.8M 0.57% 33
2024
Q4
$149M Buy
193,486
+54,212
+39% +$44.9M 0.5% 37
2024
Q3
$123M Buy
139,274
+5,682
+4% +$5.11M 0.42% 49
2024
Q2
$121M Buy
133,592
+7,702
+6% +$6.16M 0.45% 44
2024
Q1
$97.9M Buy
125,890
+93,736
+292% +$66.7M 0.37% 60
2023
Q4
$18.7M Sell
32,154
-2,192
-6% -$1.28M 0.07% 131
2023
Q3
$18.4M Sell
34,346
-1,625
-5% -$837K 0.08% 124
2023
Q2
$16.9M Sell
35,971
-834
-2% -$350K 0.07% 131
2023
Q1
$12.9M Buy
+36,805
New +$12.4M 0.06% 147

Other funds holding LLY

Empower Advisory Group's LLY Position: Q2 2026 in Review

Empower Advisory Group increased its Eli Lilly (LLY) stake by 3.2% in Q2 2026, buying an estimated $8.48M and bringing the position to 268,075 shares worth $322M. The position accounts for 0.77% of the portfolio, ranked #27.

Empower Advisory Group first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Empower Advisory Group held 268,075 shares of Eli Lilly worth $322M as of Q2 2026.
  • Empower Advisory Group bought 8,303 Eli Lilly shares in Q2 2026, an estimated $8.48M.
  • Eli Lilly made up 0.77% of Empower Advisory Group's portfolio in Q2 2026, its #27 holding.
  • Empower Advisory Group first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.